NeuroMetrix shares pop after receiving milestone payment under tie-up with GlaxoSmithKline
NeuroMetrix has ceded ownership of its Quell technology for markets outside the US to Glaxo's consumer health care division
Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 25 of 38
Bidding war brewing for GSK’s Indian Horlicks division, with Coca-Cola, Nestle and Kraft all reportedly interested
Horlicks might not be big business in the UK anymore, but it is India, where hundreds of thousands of kids drink it every day for breakfast
GlaxoSmithKline reports positive results from phase III trial of its two-drug HIV treatment
The GEMINI trials showed that HIV could be treated with a two-drug regimen, as opposed to the cocktail of three or more drugs which sufferers currently have to take
Glaxo makes new drug application in Japan for COPD treatment, Trelegy Ellipta
"We look forward to a decision from the MHLW, which, if positive, would provide a new therapeutic option for appropriate patients with COPD in Japan," said Dr Ted Witek, the senior vice president and chief scientific officer at Innoviva
Investments and investor services
FTSE 100 closes higher, given a leg-up by weaker pound
The blue-chip index closed around 38 points higher at 7,700
Investments and investor services
Will BT Group be able to avoid cutting its dividend?
Thursday is set to be a busy one for corporate results with the likes of BT Group, Barratt Developments, Next and Supergroup among the day's highlights.
GlaxoSmithKline CFO Simon Dingemans to retire next May
Simon Dingemans has been with GSK for seven years, but he will hang up his boots in 12 months’ time
Archive
Rate hike unlikely from May Bank of England policy meeting after recent dull UK data
Aside from the latest Bank of England interest rate decision, the week ahead includes updates from Wm Morrison Supermarkets, Next, BT Group, ITV, and William Hill ...
GSK rules out Shire bid as it reports drop in quarterly earnings
The drugmaker reported a 2% decline in first quarter adjusted earnings as a stronger pound and pricing pressure provided a drag
Stellar Diamonds shares leap as court approves its acquisition by NWF
A look at some of the biggest risers and fallers in London on Wednesday
FTSE 100 pares losses as US bond yields rise above 3%
Resource stocks suffer as US dollar makes headway on forex markets
Archive
Big results day for banks and drugs as Lloyds and GlaxoSmithKline step up to the plate
Day ahead includes first-quarter updates from blue chip firms Lloyds Banking Group, GlaxoSmithKline, Whitbread, and Persimmon ...
Investments and investor services
FTSE 100 closes higher, buoyed by hopes for City post-Brexit
FTSE 100 closed around 30 points higher at 7,398 on Minday
Archive
Lloyds, Barclays, RBS, GSK and Shire kick off earnings season for banks and pharmas
The week ahead in includes updates from Lloyds, Barclays, RBS, Shire, GSK, Whitbread, Persimmon and Shell
AstraZeneca and GlaxoSmithKline share price targets tweaked and on Jefferies' 'buy' ahead of Q1 results season for the druggies
The broker is still enamoured of the UK big hitters but doesn't expect it to be plain sailing for either
Strong growth in portfolio value matched by share price rise for incubator Frontier IP Group
The AIM-listed intellectual property group’s investments were worth £8mln as at the end of December 2017, helped by the additions of The Vaccine Group and water pollution tester Molendotech
GSK buys out consumer healthcare venture partner Novartis for US$13bn
The news comes just days after GSK bowed out of the race to take over the consumer healthcare unit of Pfizer
FTSE 100 stages rebound as trade war fears ease
In the currency markets, the pound shed 0.17% against the Euro, and lost 0.46% against the US dollar
GlaxoSmithKline follows Reckitt Benckiser in bowing out of US$20bn auction for Pfizer consumer division
Bidders seem to be dropping like flies and it's unclear just who is left in the auction
FTSE 100 closes down on trade war concerns as market awaits Brexit transition deal approval
Will EU leaders approve the Brexit transition deal reached between Michel Barnier and David Davis?